OPEN END TURBO OPTIONSSCHEIN SHORT - RESMED | Market Closed - BOERSE MUENCHEN 19:26:58 12/06/2024 BST | ||
| 4.36 EUR | -2.24% |
|
| Current month | -11.92% | ||
| 1 month | +2.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 12/06/24 | 4.36 | -2.24% |
| 11/06/24 | 4.46 | -1.76% |
| 10/06/24 | 4.54 | +1.34% |
| 07/06/24 | 4.48 | -0.44% |
| 06/06/24 | 4.5 | +2.97% |
Real-time BOERSE MUENCHEN
Last update June 12, 2024 at 07:26 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Goldman Sachs |
| WKN | GK9LSP |
| ISIN | DE000GK9LSP7 |
| Date issued | 25/08/2022 |
| Strike | 259.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.54 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.2 € |
|---|---|
| Lowest since issue | 2.14 € |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
210.9
USD
Average target price
218.7
USD
Spread / Average Target
+3.71%
- Stock Market
- Certificates
- Certificat
